ERVW-1 and myeloid sarcoma: This is based on the demonstration of activated HERV-H [10,11] and MSRV/HERV-W [12,13] - virions - in blood from MS patients, and increased levels of HERV-H, HERV-K, and HERV-W RNA in MS brains [14].